Emergency Use

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report

Covaxin Booster Jabs Trial Shows 'Long-Term Safety With No Adverse Events': Bharat Biotech

Aurobindo Pharma Launches Covid Drug Molnupiravir After ICMR Chief’s ‘Major Safety Concerns’ Advice

Covid Vaccine: Health Ministry Gives Nod To Emergency Use Of Covovax, Corbevax & Molnupiravir Drug

Bharat Biotech's Covaxin Get DCGI Nod For Emergency Use For Children Aged Above 12 Yrs

US FDA Authorises Pfizer Covid Booster Dose For Those Aged 16 & 17 Amid Omicron Threat

Negativity ‘Hurt Us’: Bharat Biotech Chairman Dr Krishna Ella On Delay In WHO Nod To Covaxin

Novavax Files For Emergency Use Listing For Its Covid-19 Vaccine Candidate With WHO

WHO Approves Bharat Biotech's Covaxin For Emergency Use Listing

G20 Leaders To Strengthen WHO In Optimising Covid Vaccine Approval Process: Piyush Goyal

'Bharat Biotech Submitting Data Regularly': WHO On Covaxin Getting EUL Nod